Clement Dince

Clement Dince currently serves as the Partnerships & Business Director at SEQENS Biotechnologies, a leading division within SEQENS dedicated to advancing innovative solutions in the biotech and specialty chemicals sectors. In this strategic role, Clement leverages his extensive background in organic chemistry, biocatalysis, and analytical techniques such as NMR spectroscopy and HPLC to identify and cultivate new business opportunities across diverse industries, including flavors & fragrances, agrochemicals, cosmetics, and specialty chemicals. His expertise in enzymology and total synthesis positions him uniquely to foster collaborations that drive the development of sustainable, high-value biotechnological products.

At SEQENS, Clement’s key projects often involve establishing partnerships with biotech startups, academic institutions, and industry leaders to co-develop novel enzyme-based processes and biocatalytic solutions. His deep understanding of organic chemistry and analytical methods enables him to evaluate and optimize bioprocesses, ensuring they meet the rigorous standards of quality and efficiency demanded by clients. Clement’s open-minded and social approach facilitates strong relationship-building, essential for navigating complex negotiations and aligning strategic objectives with partners’ innovation pipelines.

With a proven track record of working in both academic and industrial laboratories—including UC Berkeley, ETH Zürich, and Rhodia—Clement brings a high level of analytical thinking and organizational skills to his role. His enthusiasm for the intersection of chemistry and biology fuels his commitment to expanding SEQENS’ footprint in biotechnologies, fostering collaborations that accelerate the development of sustainable solutions in the flavors & fragrances, agrochemistry, and cosmetics sectors. Ultimately, Clement’s leadership helps position SEQENS as a pioneer in biotechnological innovation, emphasizing the transformative potential of enzyme engineering and biocatalysis.